These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31949471)

  • 1. The Effect of Compound
    Yin W; Zhong G; Fan H; Xia H
    Evid Based Complement Alternat Med; 2019; 2019():7564232. PubMed ID: 31949471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of 5-fluorouracil on the expression of ATP-binding cassette superfamily G member 2 in human colon cancer cell SW480].
    Qu JM; You J; Liu HG; Huang QD; Guo GL
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jan; 16(1):89-92. PubMed ID: 23355249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines.
    Liu Z; Qiu M; Tang QL; Liu M; Lang N; Bi F
    Chin J Cancer; 2010 Jul; 29(7):661-7. PubMed ID: 20591218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein.
    He WT; Zhu YH; Zhang T; Abulimiti P; Zeng FY; Zhang LP; Luo LJ; Xie XM; Zhang HL
    Chin J Integr Med; 2019 Jun; 25(6):416-424. PubMed ID: 30484020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gfi-1 modulates HMGB1-Mediated autophagy to overcome oxaliplatin resistance in colorectal cancer.
    Liu W; Zhang Z; Zhang L; Jiang X; Chen C; Wu X; Zhao Q
    Heliyon; 2024 May; 10(9):e29859. PubMed ID: 38694127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zuo Jin Wan Reverses the Resistance of Colorectal Cancer to Oxaliplatin by Regulating the MALAT1/miR-200s/JNK Signaling Pathway.
    Wei Z; Zhou J; Yu H; Pu Y; Cheng Y; Zhang Y; Ji Q; Zhu H
    Evid Based Complement Alternat Med; 2022; 2022():3032407. PubMed ID: 36248422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
    Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY
    Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body hyperthermia (41.8 degrees C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study.
    Hegewisch-Becker S; Gruber Y; Corovic A; Pichlmeier U; Atanackovic D; Nierhaus A; Hossfeld DK
    Ann Oncol; 2002 Aug; 13(8):1197-204. PubMed ID: 12181242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines.
    Qin B; Tanaka R; Shibata Y; Arita S; Ariyama H; Kusaba H; Baba E; Harada M; Nakano S
    Anticancer Drugs; 2006 Apr; 17(4):445-53. PubMed ID: 16550003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal effect of ginsenoside Rh2 on oxaliplatin-resistant colon cancer cells and its mechanism.
    Ma J; Gao G; Lu H; Fang D; Li L; Wei G; Chen A; Yang Y; Zhang H; Huo J
    Exp Ther Med; 2019 Jul; 18(1):630-636. PubMed ID: 31258699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Less cytotoxicity to combination therapy of 5-fluorouracil and cisplatin than 5-fluorouracil alone in human colon cancer cell lines.
    Chen XX; Lai MD; Zhang YL; Huang Q
    World J Gastroenterol; 2002 Oct; 8(5):841-6. PubMed ID: 12378627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan.
    Boyer J; McLean EG; Aroori S; Wilson P; McCulla A; Carey PD; Longley DB; Johnston PG
    Clin Cancer Res; 2004 Mar; 10(6):2158-67. PubMed ID: 15041737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irinotecan overcomes the resistance to 5-fluorouracil in human colon cancer xenografts by down-regulation of intratumoral thymidylate synthase.
    Fukushima M; Sakamoto K; Ohshimo H; Nakagawa F; Taguchi T
    Oncol Rep; 2010 Oct; 24(4):835-42. PubMed ID: 20811661
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Li Q; Wang X; Shen A; Zhang Y; Chen Y; Sferra TJ; Lin J; Peng J
    Exp Ther Med; 2015 Nov; 10(5):1845-1850. PubMed ID: 26640560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of the combination of oxaliplatin, irinotecan and continuous infusion 5-fluorouracil in digestive tumors.
    Abad A; Massutí B; Gallego J; Yuste AL; Manzano JL; Carrato A; Antón A; Marfa X; Diaz-Rubio E;
    Anticancer Drugs; 2004 Jun; 15(5):469-71. PubMed ID: 15166620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role and mechanism research on reversal of 5-fluorouracil resistance by epigallocatechin gallate in gastric cancer drug-resistance cells lines SGC-7901/5-FU].
    Tang H; Zhang X; Cui S; Wang J; Ruan Q; Huang Y; Yang D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1170-1175. PubMed ID: 27781257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma.
    Martoni A; Mini E; Pinto C; Nobili S; Gentile AL; Dentico P; Angelelli B; Scicolone S; Piana E; Mazzei T
    Ann Oncol; 2001 Apr; 12(4):519-24. PubMed ID: 11398887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.
    Fioravanti A; Canu B; Alì G; Orlandi P; Allegrini G; Di Desidero T; Emmenegger U; Fontanini G; Danesi R; Del Tacca M; Falcone A; Bocci G
    Eur J Pharmacol; 2009 Oct; 619(1-3):8-14. PubMed ID: 19695243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-124 Intensified Oxaliplatin-Based Chemotherapy by Targeting CAPN2 in Colorectal Cancer.
    Xie XQ; Wang MJ; Li Y; Lei LP; Wang N; Lv ZY; Chen KL; Zhou B; Ping J; Zhou ZG; Sun XF
    Mol Ther Oncolytics; 2020 Jun; 17():320-331. PubMed ID: 32382656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.